What is the catalog number for Ibandronic acid?

The catalog number for Ibandronic acid is HY-B0515A.

What sizes are available for Ibandronic acid?

Ibandronic acid is available in the following size(s): 1 Each.

Is Ibandronic acid in stock?

Ibandronic acid is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Ibandronic acid?

Ibandronic acid is manufactured by QuantiMol.

What is the estimated delivery time for Ibandronic acid?

Estimated delivery time for Ibandronic acid is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Ibandronic acid?

The safety data sheet for Ibandronic acid is available here: http://file.medchemexpress.com/batch_PDF/HY-B0515A/.

Ibandronic acid

Ibandronic acid is a highly effective nitrogen-containing bisphosphonate that can be used for osteoporosis.

Product Specifications

CAS Number

114084-78-5

UNSPSC

12352211

Hazard Statement

H302-H315-H319-H335

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/Ibandronic-acid.html

Solubility

10 mM in DMSO

Smiles

OC(P(O)(O)=O)(P(O)(O)=O)CCN(C)CCCCC

Molecular Formula

C9H23NO7P2

Molecular Weight

319.23

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78 (3) : p. 453-8.|[2]Epplen, R., et al., Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol, 2011. 50 (1) : p. 127-33.|[3]Chesnut, I.C., et al., Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res, 2004. 19 (8) : p. 1241-9.|[4]Bauss, F., et al., Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol, 2002. 29 (10) : p. 2200-8.